At its 1H2026 results briefing, Kweichow Moutai director Wang Li (acting GM) said the company will not release additional market supply of Moutai 1935 in 2026. Distributor contract execution is near 80%, terminal sell‑through is strong and channel inventories are in a healthy range. The company will allocate remaining plan volume according to market conditions, boost consumer‑facing marketing spend, cancel distributor sales incentives for deliveries priced below contract, tighten expense audits

At its 1H2026 results briefing, Kweichow Moutai director Wang Li (acting GM) said the company will not release additional market supply of Moutai 1935 in 2026. Distributor contract execution is near 80%, terminal sell‑through is strong and channel inventories are in a healthy range. The company will allocate remaining plan volume according to market conditions, boost consumer‑facing marketing spend, cancel distributor sales incentives for deliveries priced below contract, tighten expense audits and crack down on fee extraction and related violations.